Titanium Zirconium (TiZr) Mini Implants
Is the Stabilization of a Mandibular Overdenture Employing Four Novel One-piece Immediately Loaded TiZr Implants With Miniaturized Stud-type Attachments a Feasible Alternative to Two Two-piece Early Loaded Tissue-level Implants With Regular Stud-type Attachments?
1 other identifier
interventional
72
1 country
2
Brief Summary
H0: "Within the first year post-placement, four interforaminally placed, immediately loaded 2.4 mm narrow-diameter one-piece TiZr implants with miniaturized stud-type attachments show improved patient-reported outcome measures (PROMS) compared to two interforaminally placed, early loaded, TiZr two-piece implants with stud-type attachments to retain a mandibular overdenture."The specific aim is to compare both treatment alternatives to evaluate which one may be recommended for elderly edentulous patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2019
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2019
CompletedFirst Posted
Study publicly available on registry
February 12, 2019
CompletedStudy Start
First participant enrolled
September 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2033
ExpectedFebruary 18, 2026
February 1, 2026
5 years
January 30, 2019
February 16, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Geriatric Oral Health Assessment Index (GOHAI)
Change from baseline questionnaires in Oral Health Related Quality of Life (OHRQoL). Scores 0-60: higher values represent lower OHRQoL
One-year follow-up
Secondary Outcomes (12)
Additional Oral Health Impact Profile for edentulism (OHIP-EDENT)
Follow-up (up to 365 days)
Additional PROM Denture Satisfaction Index (DSI)
Baseline, follow-up (up to 365 days)
Implant Survival
at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up
Implant Success
at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up
Prosthetic Survival
Baseline, follow-up (up to 365 days)
- +7 more secondary outcomes
Study Arms (2)
Control-group
EXPERIMENTALTwo Tissue Level TiZr Sand blasted long grit acid-etched (SLA) implants placed in positions 33 and 43 (diameter 3.3mm, length ≥10mm), early loading
Experimental-group
EXPERIMENTALFour narrow-diameter implants (NDI) TiZr SLA implants in positions 34, 32, 42, and 44 (diameter 2.4mm, length ≥10mm), immediate loading
Interventions
Eligibility Criteria
You may qualify if:
- At patient level:
- Written informed consent
- Age ≥ 18 years
- Sufficient complete dentures (Marxkors and Ferger, 1989) not older than 1 year
- Patient is unsatisfied with mandibular denture to the degree that he/she seeks treatment
- At site level:
- Healed edentulous mandible (minimum 8 weeks since last extraction)
- Minimal ridge dimensions 5.5 mm (width) by 12 mm (height) in the anterior (interforaminal) area, allowing the placement of 3.3 (endosseous diameter) by 10 mm (length) implants
- Opposing dentition: complete denture on a edentulous maxilla
- Physical status (PS) 1 and 2 (American Society of Anesthesiologists)
You may not qualify if:
- At patient level
- Any physical or mental disorder that would interfere with the ability to perform adequate oral hygiene or the capability of providing written informed consent and compliance to the protocol
- Any disorder that would interfere with wound healing or represent a contraindication for oral surgery such as, but not limited to, uncontrolled diabetes or conditions resulting in or requiring immunosuppression, radiation, chemotherapy, frequent use of antibiotics or antiresorptive medication such as bisphosphonates
- Pregnancy or lactation
- Heavy smoking habit with \> 20 cig/d
- Severe bruxism or clenching habits, present oro-facial pain
- At site level:
- Ridge defects requiring staged bone augmentation procedures (simultaneous Guided Bone Regeneration (GBR) within the ridge contour allowed)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Private Practice Dr. B. Wallkamm
Langenthal, Canton of Bern, 4900, Switzerland
University of Bern
Bern, 3010, Switzerland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Beat Wallkamm, Dr
Private Practice
- STUDY DIRECTOR
Martin Schimmel, Prof
University of Bern
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 30, 2019
First Posted
February 12, 2019
Study Start
September 1, 2019
Primary Completion
September 10, 2024
Study Completion (Estimated)
August 1, 2033
Last Updated
February 18, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
It is not planned to use the data of this study for future research.